JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
SHANGHAI, April 30, 2025 /PRNewswire/ -- JediCare Medical Technology Co., Ltd. a Shanghai, China based company ("the Company"), jointly with West China Hospital of Sichuan University, recently announced the successful completion of first-in-human...
Global Times: Xi's pre-Spring Festival visits to the grassroots reflect 'people-first' philosophy
BEIJING, Jan. 24, 2025 /PRNewswire/ -- As the Year of the Snake draws near, Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee, on Thursday inspected Shenyang, capital city of Northeast China's Liaoning Province....
Fibocom Debuts Industry-first "AI Buddy" Set to Expand AI-enhanced Interaction to Consumer-centric Scenarios at CES 2025
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Fibocom (Stock code: 300638), a global leading provider of AIoT solutions and wireless communication modules, debuts the industry-first "AI Buddy" catering to bring an AI-enhanced real-time interaction to...
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the...
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups. PK results support once a...
